VISP Trial Analysis Says High-Dose B Vitamin Mix Lowers Stroke Risk
This article was originally published in The Tan Sheet
Executive Summary
High doses of a combined B vitamin therapy yielded a 21% reduction in risk of stroke and other negative outcomes compared to low doses, an "efficacy analysis" of the VISP trial found